Alterola Biotech (ABTI) Financial Statements
Alterola Biotech Financial Overview
Alterola Biotech's market cap is currently $291.90K. The company's EPS TTM is $-0.00; its P/E ratio is -0.10; Alterola Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 23 | Mar 22 | Sep 20 | Sep 19 | Sep 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.90M | $ -6.47M | $ -329.51K | $ -258.45K | $ -122.56K |
| EBITDA | $ 135.87K | $ 6.47M | $ -20.01K | ― | $ -122.56K |
| Net Income | $ -1.54M | $ -6.47M | $ -171.51K | $ -258.70K | $ -133.07K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.89K | $ 63.82K | $ 15.27K | $ 0.00 | $ 0.00 |
| Total Assets | $ 12.38M | $ 12.13M | $ 15.27K | $ 14.74K | $ 50.74K |
| Total Debt | $ 1.41M | $ 164.22K | $ 0.00 | $ 0.00 | $ 19.95K |
| Net Debt | $ 1.41M | $ 100.40K | $ -15.27K | $ 0.00 | $ 19.95K |
| Total Liabilities | $ 2.28M | $ 1.20M | $ 338.49K | $ 217.45K | $ 106.31K |
| Stockholders' Equity | $ 10.10M | $ 10.93M | $ -323.22K | $ -202.71K | $ -55.57K |
| Cash Flow | |||||
| Free Cash Flow | $ -1.18M | $ 44.34K | $ 530.00 | $ 0.00 | $ -19.95K |
| Operating Cash Flow | $ -1.04M | $ 44.34K | $ 531.00 | $ 0.00 | $ -19.95K |
| Investing Cash Flow | $ -139.80K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 1.21M | $ -9.67K | $ 0.00 | $ 0.00 | $ 19.95K |
Currency in USD